Logo

Oxford GlycoSciences CEO Kranda to Step Down

Mar 07, 2002

NEW YORK, March 7 - Oxford GlycoSciences on Thursday said that CEO Michael Kranda will step down by the end of this year.

The company said Kranda, who has been at OGS for six years, cited "personal family reasons" for his decision to leave. Chairman G. Kirk Raab said the company has begun looking for a replacement.

 

Kranda "will stay on through the transition period and I am confident that OGS' programmes and progress will continue unabated," Raab said in a statement.

Breaking News
The Scan

Nucleotide Base Detected on Near-Earth Asteroid

Among other intriguing compounds, researchers find the nucleotide uracil, a component of RNA sequences, in samples collected from the near-Earth asteroid Ryugu, as they report in Nature Communications.

Clinical Trial Participants, Investigators Point to Importance of Clinical Trial Results Reporting in Canadian Study

Public reporting on clinical trial results is crucial, according to qualitative interviews with clinical trial participants, investigators, and organizers from three provinces appearing in BMJ Open.

Old Order Amish Analysis Highlights Autozygosity, Potential Ties to Blood Measures

Researchers in BMC Genomics see larger and more frequent runs-of-homozygosity in Old Order Amish participants, though only regional autozygosity coincided with two blood-based measures.

Suicidal Ideation-Linked Loci Identified Using Million Veteran Program Data

Researchers in PLOS Genetics identify risk variants within and across ancestry groups with a genome-wide association study involving veterans with or without a history of suicidal ideation.